Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Tenon Medical (TNON) Shares Issued (2023 - 2025)

Tenon Medical's quarterly Shares Issued came in at $4.0 million in Q1 2025, up 101.51% year-on-year from $2.0 million in Q1 2024, and up 7135.09% quarter-over-quarter from -$57000.0 in Q4 2024.

Tenon Medical has reported Shares Issued for 3 years, with the latest figure at $4.0 million in Q1 2025.

  • For the quarter ending Q1 2025, Shares Issued rose 101.51% year-over-year to $4.0 million; the trailing twelve-month figure through Jun 2025 stood at $4.1 million (up 261.17% YoY), and the FY2024 full-year result was $2.1 million, up 716.28% from the prior year.
  • Shares Issued for Q1 2025 stood at $4.0 million, up from -$57000.0 in the prior quarter.
  • The five-year high for Shares Issued was $4.0 million in Q1 2025, with the low at -$4.4 million in Q3 2023.
  • Average Shares Issued over 3 years is $261000.0, with a median of $58000.0 recorded in 2024.
  • Peak annual rise in Shares Issued reached 103.97% in 2024, while the deepest fall reached 70.77% in 2024.
  • Tracing TNON's Shares Issued over 3 years: stood at -$195000.0 in 2023, then soared by 70.77% to -$57000.0 in 2024, then soared by 7135.09% to $4.0 million in 2025.
  • The last three Shares Issued figures came in at $4.0 million (Q1 2025), -$57000.0 (Q4 2024), and $173000.0 (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 116.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 164.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 81.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 68.90 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 12.70 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Tenon Medical 7,436.88 -4.60 Mn 945,000.00 -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2025 4.01 Mn
Mar 31, 2025 4.01 Mn
Dec 31, 2024 -1.35 Mn
Dec 31, 2024 -1.35 Mn
Sep 30, 2024 173,000.00
Sep 30, 2024 173,000.00
Mar 31, 2024 1.99 Mn
Mar 31, 2024 1.99 Mn
Dec 31, 2023 42,000.00
Dec 31, 2023 42,000.00
Sep 30, 2023 -4.36 Mn
Sep 30, 2023 -4.36 Mn